Bodor Laboratories, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bodor Laboratories, Inc..The latest application filed is for "formulation for soft anticholinergic analogs".
Company Profile
22.36.33
Trademarks
- Bodor Laboratories, Inc. - Miami FL US
- Bodor Laboratories, Inc. -
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Potent soft anti-inflammatory corticosteroid compounds and uses thereof Grant 11,447,522 - Bodor September 20, 2 | 2022-09-20 |
| Formulation For Soft Anticholinergic Analogs App 20220000839 - BODOR; Nicholas S. ; et al. | 2022-01-06 |
| Formulation for soft anticholinergic analogs Grant 11,123,325 - Bodor , et al. September 21, 2 | 2021-09-21 |
| Formulation for soft anticholinergic analogs Grant 11,084,788 - Bodor , et al. August 10, 2 | 2021-08-10 |
| Formulation For Soft Anticholinergic Analogs App 20210228544 - BODOR; Nicholas S. ; et al. | 2021-07-29 |
| Formulation for soft anticholinergic analogs Grant 11,052,067 - Bodor , et al. July 6, 2 | 2021-07-06 |
| Formulation For Soft Anticholinergic Analogs App 20210198195 - BODOR; NICHOLAS S. ; et al. | 2021-07-01 |
| Formulation for soft anticholinergic analogs Grant 11,034,652 - Bodor , et al. June 15, 2 | 2021-06-15 |
| Formulation for soft anticholinergic analogs Grant 11,026,919 - Bodor , et al. June 8, 2 | 2021-06-08 |
| Formulation for soft anticholinergic analogs Grant 10,961,191 - Bodor , et al. March 30, 2 | 2021-03-30 |
| Formulation for soft anticholinergic analogs Grant 10,959,983 - Bodor , et al. March 30, 2 | 2021-03-30 |
| Formulation For Soft Anticholinergic Analogs App 20210087142 - BODOR; NICHOLAS S. ; et al. | 2021-03-25 |
| Formulation for soft anticholinergic analogs Grant 10,952,990 - Bodor , et al. March 23, 2 | 2021-03-23 |
| Formulation For Soft Anticholinergic Analogs App 20210077459 - BODOR; Nicholas S. ; et al. | 2021-03-18 |
| Formulation For Soft Anticholinergic Analogs App 20210077460 - BODOR; Nicholas S. ; et al. | 2021-03-18 |
| Formulation For Soft Anticholinergic Analogs App 20210078946 - BODOR; NICHOLAS S. ; et al. | 2021-03-18 |
| Formulation for soft anticholinergic analogs Grant 10,947,192 - Bodor , et al. March 16, 2 | 2021-03-16 |
| Method of dosing and use of soft anticholinergic esters Grant 10,772,867 - Bodor , et al. Sept | 2020-09-15 |
| Potent Soft Anti-inflammatory Corticosteroid Compounds And Uses Thereof App 20200181191 - BODOR; Nicholas S. | 2020-06-11 |
| Use of selected anticholinergic zwitterions Grant 10,632,067 - Bodor | 2020-04-28 |
| Formulation For Soft Anticholinergic Analogs App 20200121643 - BODOR; Nicholas S. ; et al. | 2020-04-23 |
| Formulation For Soft Anticholinergic Analogs App 20200113869 - BODOR; NICHOLAS S. ; et al. | 2020-04-16 |
| Formulation For Soft Anticholinergic Analogs App 20200101044 - BODOR; Nicholas S. ; et al. | 2020-04-02 |
| Formulation For Soft Anticholinergic Analogs App 20200093791 - BODOR; NICHOLAS S. ; et al. | 2020-03-26 |
| Method Of Dosing And Use Of Soft Anticholinergic Esters App 20190328707 - BODOR; NICHOLAS S. ; et al. | 2019-10-31 |
| Method of dosing and use of soft anticholinergic esters Grant 10,383,846 - Bodor , et al. A | 2019-08-20 |
| Formulation For Soft Anticholinergic Analogs App 20190247362 - BODOR; Nicholas S. ; et al. | 2019-08-15 |
| Compositions And Methods For Treatment Of Copd App 20190224164 - BODOR; Nicholas S. | 2019-07-25 |
| Use of selected anticholinergic zwitterions Grant 10,335,367 - Bodor | 2019-07-02 |
| Methods And Compositions For Soft Anticholinergic Esters App 20180250265 - BODOR; Nicholas S. | 2018-09-06 |
| Use Of Selected Anticholinergic Zwitterions App 20180243209 - BODOR; Nicholas S. | 2018-08-30 |
| Methods And Compositions For Soft Anticholinergic Zwitterions App 20180235869 - BODOR; Nicholas S. | 2018-08-23 |
| Formulation For Soft Anticholinergic Analogs App 20180228770 - BODOR; Nicholas S. ; et al. | 2018-08-16 |
| Method of dosing and use of soft anticholinergic esters App 20180185331 - Bodor; Nicholas S. ; et al. | 2018-07-05 |
| Method of dosing and use of soft anticholinergic esters Grant 9,895,350 - Bodor , et al. February 20, 2 | 2018-02-20 |
| Formulation For Soft Anticholinergic Analogs App 20180021300 - BODOR; Nicholas S. ; et al. | 2018-01-25 |
| Formulation For Soft Anticholinergic Analogs App 20170020845 - BODOR; NICHOLAS S. ; et al. | 2017-01-26 |
| Method of dosing and use of soft anticholinergic esters Grant 9,492,429 - Bodor , et al. November 15, 2 | 2016-11-15 |
| Method Of Dosing And Use Of Soft Anticholinergic Esters App 20160310464 - BODOR; NICHOLAS S. ; et al. | 2016-10-27 |
| Method Of Dosing And Use Of Soft Anticholinergic Esters App 20160067214 - BODOR; NICHOLAS S. ; et al. | 2016-03-10 |
| Use Of Selected Anticholinergic Zwitterions App 20150374621 - BODOR; Nicholas S. | 2015-12-31 |
| Method of dosing and use of soft anticholinergic esters Grant 9,220,707 - Bodor , et al. December 29, 2 | 2015-12-29 |
| Formulation For Soft Anticholinergic Analogs App 20150320722 - BODOR; Nicholas S. ; et al. | 2015-11-12 |
| Method Of Dosing And Use Of Soft Anticholinergic Esters App 20140275204 - BODOR; NICHOLAS S. ; et al. | 2014-09-18 |
| Treatment of eyelid dermatitis Grant 8,835,410 - Bodor September 16, 2 | 2014-09-16 |
| Soft anticholinergic esters Grant 8,628,759 - Bodor January 14, 2 | 2014-01-14 |
Company Registrations
| NCAGE Code | 5BLM9 | BODOR LABORATORIES INC. |
| CAGE Code | 5BLM9 | BODOR LABORATORIES INC. |
| S.A.M. Registration | 5BLM9 [829534036] | BODOR LABORATORIES INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 